Karin Förster

652 total citations
5 papers, 178 citations indexed

About

Karin Förster is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Organic Chemistry. According to data from OpenAlex, Karin Förster has authored 5 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 1 paper in Organic Chemistry. Recurrent topics in Karin Förster's work include Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers) and Inflammatory mediators and NSAID effects (1 paper). Karin Förster is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Asthma and respiratory diseases (3 papers) and Inflammatory mediators and NSAID effects (1 paper). Karin Förster collaborates with scholars based in Germany, Sweden and Estonia. Karin Förster's co-authors include A. Reichelt, Michael J. M. Fischer, Lucio C. Rovati, I Setnikar, Heather Wray, Beatrix Bálint, Marie Cullberg, Anneliese Linnhoff, Henrik Watz and B. Larsson and has published in prestigious journals such as Respiratory Medicine, Pulmonary Pharmacology & Therapeutics and PubMed.

In The Last Decade

Karin Förster

4 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karin Förster Germany	4	66	52	49	44	39	5	178
Autumn Guyer United States	8	23 0.3×	47 0.9×	44 0.9×	27 0.6×	180 4.6×	16	248
Daniele Urzì Italy	10	98 1.5×	17 0.3×	52 1.1×	6 0.1×	24 0.6×	17	266
Yang Su China	11	29 0.4×	16 0.3×	14 0.3×	31 0.7×	7 0.2×	30	246
Jiaxuan Wang China	8	20 0.3×	31 0.6×	7 0.1×	20 0.5×	14 0.4×	29	161
Chihiro Mitsui Japan	8	120 1.8×	186 3.6×	26 0.5×	35 0.8×	74 1.9×	23	256
Sanjeev Khindri United Kingdom	9	253 3.8×	248 4.8×	22 0.4×	41 0.9×	5 0.1×	24	366
Dimitrios Papaioannides Greece	6	45 0.7×	40 0.8×	13 0.3×	14 0.3×	20 0.5×	10	154
Quang Luu Quoc South Korea	10	75 1.1×	160 3.1×	18 0.4×	99 2.3×	12 0.3×	22	253
Anna James Sweden	6	108 1.6×	127 2.4×	7 0.1×	22 0.5×	28 0.7×	9	183
Wen Y. Ding United Kingdom	5	20 0.3×	10 0.2×	38 0.8×	14 0.3×	79 2.0×	7	198

Countries citing papers authored by Karin Förster

Since Specialization

Citations

This map shows the geographic impact of Karin Förster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Förster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Förster more than expected).

Fields of papers citing papers by Karin Förster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Förster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Förster. The network helps show where Karin Förster may publish in the future.

Co-authorship network of co-authors of Karin Förster

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Förster. A scholar is included among the top collaborators of Karin Förster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Förster. Karin Förster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Förster, Karin, Anneliese Linnhoff, Beatrix Bálint, et al.. (2015). The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD. Pulmonary Pharmacology & Therapeutics. 31. 36–41. 73 indexed citations

2.

Geßner, Christian, Stephanie Korn, Wolfgang Schürmann, et al.. (2014). Once-daily QVA149 improves lung function and dyspnoea compared with tiotropium plus formoterol: The QUANTIFY study. 44. 899. 1 indexed citations

3.

Kirsten, Anne, Karin Förster, Anneliese Linnhoff, et al.. (2012). The safety and tolerability of twice-daily oral doses of AZD5069, a novel CXCR2 antagonist, in patients with moderate-to-severe COPD. 40. 3083. 3 indexed citations

4.

Worth, H., Karin Förster, Göran Eriksson, et al.. (2010). Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD. Respiratory Medicine. 104(10). 1450–1459. 35 indexed citations

5.

Reichelt, A., Karin Förster, Michael J. M. Fischer, Lucio C. Rovati, & I Setnikar. (1994). Efficacy and safety of intramuscular glucosamine sulfate in osteoarthritis of the knee. A randomised, placebo-controlled, double-blind study.. PubMed. 44(1). 75–80. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact